Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-582-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 376, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
SSR1 hsa-miR-582-3p low: 0 high: 2 2 2 2 0.735
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr6:7301458-7301476 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr6:7301458-7301476 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC38A2 hsa-miR-582-3p low: 0 high: 2 2 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:46359722-46359736 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:46358814-46358837 PAR-CLIP POSITIVE DIRECT TarBase 7.0
NCOA2 hsa-miR-582-3p low: 0 high: 2 2 2 2 0.696
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr8:70156663-70156690 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:70156663-70156690 PAR-CLIP POSITIVE DIRECT TarBase 7.0
BUB3 hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr10:123165320-123165329 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:123165261-123165279 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BACH1 hsa-miR-582-3p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr21:29345748-29345770 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr21:29345748-29345770 PAR-CLIP POSITIVE DIRECT TarBase 7.0
IGF2BP1 hsa-miR-582-3p low: 0 high: 2 2 2 2 0.491
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr17:49052944-49052962 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:49050819-49050842 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FEM1B hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr15:68295628-68295642 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:68295628-68295642 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BRWD1 hsa-miR-582-3p low: 0 high: 2 1 1 1 0.486
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr21:39196240-39196259 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr21:39196240-39196259 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TUBB hsa-miR-582-3p low: 0 high: 2 2 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:30724645-30724673 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr6:30724645-30724673 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PRRC2A hsa-miR-582-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr6:31631174-31631186 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr6:31631174-31631186 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TSN hsa-miR-582-3p low: 0 high: 2 1 1 1 0.802
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr2:121765474-121765494 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr2:121765474-121765494 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PPP1CB hsa-miR-582-3p low: 0 high: 2 2 2 1 0.883
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:28800087-28800107 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr2:28801538-28801558 PAR-CLIP POSITIVE DIRECT TarBase 7.0
NUCKS1 hsa-miR-582-3p low: 0 high: 2 1 1 1 0.828
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:205714576-205714595 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:205714576-205714595 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GADD45A hsa-miR-582-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:67687832-67687850 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:67687832-67687850 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EEF2 hsa-miR-582-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:3979980-3980005 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:3979980-3980005 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBE2J1 hsa-miR-582-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:89326660-89326681 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:89326638-89326663 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARF3 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:48937119-48937147 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SKAP2 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.800
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:26669456-26669475 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DHX33 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.539
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr17:5442425-5442446 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZFX hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:24214174-24214191 HITS-CLIP POSITIVE DIRECT TarBase 7.0